We showed that the supernatant of T-VEC-treated melanoma cells can partially activate BDCA-1+/BDCA-3+ myDC and that these BDCA-1+/BDCA-3+ myDC can take up co-cultured T-VEC-treated melanoma cells. Here, CD1C is linked to melanoma.